Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.
People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for ...
Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback